TRICUSPID REGURGITATION (TR)
Clinical trials for TRICUSPID REGURGITATION (TR) explained in plain language.
Never miss a new study
Get alerted when new TRICUSPID REGURGITATION (TR) trials appear
Sign up with your email to follow new studies for TRICUSPID REGURGITATION (TR), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Heart failure drug vericiguat faces new test in tricuspid regurgitation patients
Disease control Not yet recruitingThis study tests whether the drug vericiguat can improve right heart function and reduce tricuspid regurgitation in 100 adults with heart failure and reduced pumping ability. Participants take vericiguat daily for 9 months, with regular heart scans and walking tests to measure ef…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: PHASE4 • Sponsor: Daejeon St. Mary's hospital • Aim: Disease control
Last updated Jun 27, 2026 14:02 UTC
-
New heart valve device aims to fix tricuspid leak without open surgery
Disease control Not yet recruitingThis study tests a new device called the TRiCares Topaz, which replaces the tricuspid heart valve without open surgery. It is for people with severe tricuspid regurgitation (a leaky valve) who still have symptoms despite medication. The study will compare this device to another a…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: TRiCares • Aim: Disease control
Last updated Jun 27, 2026 12:29 UTC
-
New heart valve device aims to fix leaky valve without open surgery
Disease control Not yet recruitingThis study tests a new device called LuX-Valve Plus for people with a severely leaky heart valve (tricuspid regurgitation). About 680 adults will get either the new device or a standard one to see which is safer and works better. Participants will have one procedure and be follow…
Matched conditions: TRICUSPID REGURGITATION (TR)
Phase: NA • Sponsor: Jenscare Innovation Inc. • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Heart valve repair may unlock higher doses of key heart failure drugs
Knowledge-focused Not yet recruitingThis observational study will follow 50 people with severe tricuspid regurgitation (a leaky heart valve) and reduced heart function who undergo valve repair using the PASCAL Precision System. The main goal is to see if, 12 months after repair, patients can take higher doses of st…
Matched conditions: TRICUSPID REGURGITATION (TR)
Sponsor: Ceric Sàrl • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:33 UTC
-
New catheter aims to better predict heart surgery outcomes
Knowledge-focused Not yet recruitingThis study tests a special catheter that measures how well the right side of the heart is working in 8 people with severe tricuspid regurgitation (a leaky heart valve). Participants are already scheduled for a procedure to fix the valve. The goal is to see if this tool can help d…
Matched conditions: TRICUSPID REGURGITATION (TR)
Sponsor: Feldman Cardiology, PLLC • Aim: Knowledge-focused
Last updated Jun 27, 2026 12:02 UTC